ARCHIVES

Pittsburgh Broadens Misconduct Inquiry

This article is from The Cancer Letter archive.

Vol. 20 No. 22 | June 3, 1994

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Two Studies Advance The Treatment Of Early-Stage And Later Breast Cancer

June 27, 2008